Raymond James & Associates Sells 5,103 Shares of Select Medical Holdings Co. (NYSE:SEM)

Raymond James & Associates lowered its holdings in shares of Select Medical Holdings Co. (NYSE:SEM) by 1.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 261,186 shares of the health services provider’s stock after selling 5,103 shares during the period. Raymond James & Associates owned about 0.20% of Select Medical worth $9,108,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the business. Hexagon Capital Partners LLC grew its stake in Select Medical by 528.7% during the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock worth $27,000 after buying an additional 645 shares during the last quarter. Transcendent Capital Group LLC bought a new stake in Select Medical during the 2nd quarter worth about $35,000. Canada Pension Plan Investment Board acquired a new position in Select Medical in the second quarter valued at approximately $39,000. Fidelis Capital Partners LLC acquired a new position in shares of Select Medical in the 1st quarter valued at $47,000. Finally, DekaBank Deutsche Girozentrale bought a new position in Select Medical during the second quarter worth about $60,000. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Select Medical Trading Up 3.0 %

SEM opened at $33.13 on Wednesday. The company’s 50 day moving average is $34.32 and its 200-day moving average is $33.90. The company has a market cap of $4.31 billion, a P/E ratio of 15.85, a PEG ratio of 1.96 and a beta of 1.41. Select Medical Holdings Co. has a 1-year low of $21.28 and a 1-year high of $40.50. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 2.11.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, August 1st. The health services provider reported $0.60 EPS for the quarter, missing the consensus estimate of $0.61 by ($0.01). Select Medical had a return on equity of 17.50% and a net margin of 3.91%. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same period in the previous year, the firm posted $0.61 earnings per share. The firm’s quarterly revenue was up 5.1% compared to the same quarter last year. Equities research analysts predict that Select Medical Holdings Co. will post 2.03 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

SEM has been the subject of a number of research analyst reports. Bank of America started coverage on Select Medical in a research note on Tuesday, August 20th. They issued a “buy” rating and a $42.00 target price for the company. Benchmark reiterated a “buy” rating and issued a $48.00 price target on shares of Select Medical in a research note on Friday, September 6th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $39.00.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.